Literature DB >> 24279459

Inhibition of phosphoinositol 3 kinase contributes to nanoparticle-mediated exaggeration of endotoxin-induced leukocyte procoagulant activity.

Anna N Ilinskaya1, Sonny Man, Anil K Patri, Jeffrey D Clogston, Rachael M Crist, Raul E Cachau, Scott E McNeil, Marina A Dobrovolskaia.   

Abstract

AIM: Disseminated intravascular coagulation is an increasing concern for certain types of engineered nanomaterials. Recent studies have shed some light on the nanoparticle physicochemical properties contributing to this toxicity; however, the mechanisms are poorly understood. Leukocyte procoagulant activity (PCA) is a key factor contributing to the initiation of this toxicity. We have previously reported on the exaggeration of endotoxin-induced PCA by cationic dendrimers. Herein, we report an effort to discern the mechanism. MATERIALS &
METHODS: Poly(amidoamine) dendrimers with various sizes and surface functionalities were studied in vitro by the recalcification test, flow cytometry and other relevant assays. RESULTS &
CONCLUSION: Cationic dendrimers exaggerated endotoxin-induced PCA, but their anionic or neutral counterparts did not; the cationic charge prompts this phenomenon, but different cationic surface chemistries do not influence it. Cationic dendrimers and endotoxin differentially affect the PCA complex. The inhibition of phosphoinositol 3 kinase by dendrimers contributes to the exaggeration of the endotoxin-induced PCA.

Entities:  

Keywords:  coagulopathy; dendrimer; disseminated intravascular coagulation; leukocyte; nanoparticle; procoagulant activity; thrombosis

Mesh:

Substances:

Year:  2013        PMID: 24279459      PMCID: PMC4035470          DOI: 10.2217/nnm.13.137

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  54 in total

1.  Involvement of MAPK activation in bacterial endotoxin-inducible tissue factor upregulation in human monocytic THP-1 cells.

Authors:  A J Chu; Z G Wang; M A Walton; A Seto
Journal:  J Surg Res       Date:  2001-11       Impact factor: 2.192

Review 2.  Nanomedicine(s) under the microscope.

Authors:  Ruth Duncan; Rogerio Gaspar
Journal:  Mol Pharm       Date:  2011-10-26       Impact factor: 4.939

3.  Expression of tissue factor procoagulant activity: regulation by cytosolic calcium.

Authors:  R Bach; D B Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

4.  Dendrimer-induced leukocyte procoagulant activity depends on particle size and surface charge.

Authors:  Marina A Dobrovolskaia; Anil K Patri; Timothy M Potter; Jamie C Rodriguez; Jennifer B Hall; Scott E McNeil
Journal:  Nanomedicine (Lond)       Date:  2011-09-30       Impact factor: 5.307

5.  The local phospholipid environment modulates the activation of blood clotting.

Authors:  Andrew W Shaw; Vincent S Pureza; Stephen G Sligar; James H Morrissey
Journal:  J Biol Chem       Date:  2007-01-02       Impact factor: 5.157

6.  Cationic PAMAM dendrimers disrupt key platelet functions.

Authors:  Clinton F Jones; Robert A Campbell; Zechariah Franks; Christopher C Gibson; Giridhar Thiagarajan; Adriana Vieira-de-Abreu; Sivaprasad Sukavaneshvar; S Fazal Mohammad; Dean Y Li; Hamidreza Ghandehari; Andrew S Weyrich; Benjamin D Brooks; David W Grainger
Journal:  Mol Pharm       Date:  2012-05-04       Impact factor: 4.939

7.  Novel anticoagulant activity of polyamino acid offsets bacterial endotoxin-induced extrinsic hypercoagulation: downregulation of monocytic tissue factor-dependent FVII activation.

Authors:  Arthur J Chu; Mihai Rauci; Obioma I Nwobi; Suresh T Mathews; Salwa Beydoun
Journal:  J Cardiovasc Pharmacol       Date:  2003-10       Impact factor: 3.105

8.  Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes.

Authors:  H W Ziegler-Heitbrock; E Thiel; A Fütterer; V Herzog; A Wirtz; G Riethmüller
Journal:  Int J Cancer       Date:  1988-03-15       Impact factor: 7.396

Review 9.  Tissue factor in blood cells and endothelial cells.

Authors:  Bjarne Osterud; Eirik Bjorklid
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

10.  Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells.

Authors:  M P Bevilacqua; J S Pober; G R Majeau; R S Cotran; M A Gimbrone
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  8 in total

Review 1.  Immunosuppressive and anti-inflammatory properties of engineered nanomaterials.

Authors:  A N Ilinskaya; M A Dobrovolskaia
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 2.  Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications.

Authors:  Raziye Mohammadpour; Marina A Dobrovolskaia; Darwin L Cheney; Khaled F Greish; Hamidreza Ghandehari
Journal:  Adv Drug Deliv Rev       Date:  2019-07-08       Impact factor: 15.470

3.  Nanoparticle physicochemical properties determine the activation of intracellular complement.

Authors:  Anna N Ilinskaya; Ankit Shah; Alan E Enciso; King C Chan; Jan A Kaczmarczyk; Josip Blonder; Eric E Simanek; Marina A Dobrovolskaia
Journal:  Nanomedicine       Date:  2019-02-20       Impact factor: 5.307

Review 4.  Safety Challenges and Application Strategies for the Use of Dendrimers in Medicine.

Authors:  Xiang Li; Abid Naeem; Shanghua Xiao; Lei Hu; Jing Zhang; Qin Zheng
Journal:  Pharmaceutics       Date:  2022-06-17       Impact factor: 6.525

Review 5.  Current understanding of interactions between nanoparticles and the immune system.

Authors:  Marina A Dobrovolskaia; Michael Shurin; Anna A Shvedova
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-29       Impact factor: 4.219

Review 6.  Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy.

Authors:  Marina A Dobrovolskaia
Journal:  J Control Release       Date:  2015-09-05       Impact factor: 9.776

7.  Induction of Cytokines by Nucleic Acid Nanoparticles (NANPs) Depends on the Type of Delivery Carrier.

Authors:  Yelixza I Avila; Morgan Chandler; Edward Cedrone; Hannah S Newton; Melina Richardson; Jie Xu; Jeffrey D Clogston; Neill J Liptrott; Kirill A Afonin; Marina A Dobrovolskaia
Journal:  Molecules       Date:  2021-01-27       Impact factor: 4.411

Review 8.  Critical questions in development of targeted nanoparticle therapeutics.

Authors:  Richard Korsmeyer
Journal:  Regen Biomater       Date:  2016-03-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.